During the past decade, NJ Heart LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "NJ Heart LLC" are "Atrial Fibrillation" (1 trials), "Chronic Disease" (1 trials), "Pain" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "NJ Heart LLC" in a lesser frequency.

Most popular intervention types in "NJ Heart LLC" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "morphine sulfate and naltrexone hydrochloride (EMBEDA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "NJ Heart LLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "NJ Heart LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in NJ Heart LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NJ Heart LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

NJ Heart LLC has several departments that took part in Clinical trials: "NJ Heart" - 15 trials